364 related articles for article (PubMed ID: 27712844)
1. Prenatal versus Postnatal Screening for Familial Retinoblastoma.
Soliman SE; Dimaras H; Khetan V; Gardiner JA; Chan HS; Héon E; Gallie BL
Ophthalmology; 2016 Dec; 123(12):2610-2617. PubMed ID: 27712844
[TBL] [Abstract][Full Text] [Related]
2. How Eye-Preserving Therapy Affects Long-Term Overall Survival in Heritable Retinoblastoma Survivors.
Temming P; Arendt M; Viehmann A; Eisele L; Le Guin CH; Schündeln MM; Biewald E; Mäusert J; Wieland R; Bornfeld N; Sauerwein W; Eggert A; Lohmann DR; Jöckel KH
J Clin Oncol; 2016 Sep; 34(26):3183-8. PubMed ID: 27382102
[TBL] [Abstract][Full Text] [Related]
3. Knowledge of genetics in familial retinoblastoma.
Soliman SE; ElManhaly M; Dimaras H
Ophthalmic Genet; 2017; 38(3):226-232. PubMed ID: 27427836
[TBL] [Abstract][Full Text] [Related]
4. Prognostic Information for Known Genetic Carriers of RB1 Pathogenic Variants (Germline and Mosaic).
Reddy MA; Butt M; Hinds AM; Duncan C; Price EA; Sagoo MS; Onadim Z
Ophthalmol Retina; 2021 Apr; 5(4):381-387. PubMed ID: 32835838
[TBL] [Abstract][Full Text] [Related]
5. Prenatal genetic diagnosis of retinoblastoma and report of RB1 gene mutation from India.
Shah PK; Sripriya S; Narendran V; Pandian AJ
Ophthalmic Genet; 2016 Dec; 37(4):430-433. PubMed ID: 26914665
[TBL] [Abstract][Full Text] [Related]
6. Management and outcome of unilateral retinoblastoma.
Mallipatna AC; Sutherland JE; Gallie BL; Chan H; Héon E
J AAPOS; 2009 Dec; 13(6):546-50. PubMed ID: 20006813
[TBL] [Abstract][Full Text] [Related]
7. Optical Coherence Tomography-Guided Decisions in Retinoblastoma Management.
Soliman SE; VandenHoven C; MacKeen LD; Héon E; Gallie BL
Ophthalmology; 2017 Jun; 124(6):859-872. PubMed ID: 28318638
[TBL] [Abstract][Full Text] [Related]
8. Macular retinoblastoma: evaluation of tumor control, local complications, and visual outcomes for eyes treated with chemotherapy and repetitive foveal laser ablation.
Schefler AC; Cicciarelli N; Feuer W; Toledano S; Murray TG
Ophthalmology; 2007 Jan; 114(1):162-9. PubMed ID: 17070578
[TBL] [Abstract][Full Text] [Related]
9. A novel deep intronic low penetrance RB1 variant in a retinoblastoma family.
Soliman SE; Racher H; Lambourne M; Matevski D; MacDonald H; Gallie B
Ophthalmic Genet; 2018 Apr; 39(2):288-290. PubMed ID: 29099630
[No Abstract] [Full Text] [Related]
10. Psychosocial determinants for treatment decisions in familial retinoblastoma.
Soliman SE; Ulster A; MacDonald H; VandenHoven C; Toi A; Hèon E; Gallie B
Ophthalmic Genet; 2017; 38(4):392-394. PubMed ID: 28085520
[No Abstract] [Full Text] [Related]
11. A retrospective review of visual outcome and complications in the treatment of retinoblastoma.
O'Doherty M; Lanigan B; Breathnach F; O'Meara A; Gallie B; Chan H; O'Keefe M
Ir Med J; 2005 Jan; 98(1):17-20. PubMed ID: 15782728
[TBL] [Abstract][Full Text] [Related]
12. Clinical characteristics and germline mutation spectrum of RB1 in Chinese patients with retinoblastoma: A dual-center study of 145 patients.
Chai P; Luo Y; Yu J; Li Y; Yang J; Zhuang A; Fan J; Han M; Jia R
Exp Eye Res; 2021 Apr; 205():108456. PubMed ID: 33493472
[TBL] [Abstract][Full Text] [Related]
13. Spectrum of germline
Rojanaporn D; Boontawon T; Chareonsirisuthigul T; Thanapanpanich O; Attaseth T; Saengwimol D; Anurathapan U; Sujirakul T; Kaewkhaw R; Hongeng S
Mol Vis; 2018; 24():778-788. PubMed ID: 30636860
[TBL] [Abstract][Full Text] [Related]
14. [Diagnosis and treatment of retinoblastoma: current strategies for effective tumour control and preservation of vision].
Temming P; Eggert A; Bornfeld N; Sauerwein W; Göricke S; Lohmann DR
Klin Monbl Augenheilkd; 2013 Mar; 230(3):232-42. PubMed ID: 23508752
[TBL] [Abstract][Full Text] [Related]
15. Chemoreduction for group E retinoblastoma: comparison of chemoreduction alone versus chemoreduction plus low-dose external radiotherapy in 76 eyes.
Shields CL; Ramasubramanian A; Thangappan A; Hartzell K; Leahey A; Meadows AT; Shields JA
Ophthalmology; 2009 Mar; 116(3):544-551.e1. PubMed ID: 19157557
[TBL] [Abstract][Full Text] [Related]
16. Detection and reporting of RB1 promoter hypermethylation in diagnostic screening.
Price EA; Kolkiewicz K; Patel R; Hashim S; Karaa E; Scheimberg I; Sagoo MS; Reddy MA; Onadim Z
Ophthalmic Genet; 2018 Aug; 39(4):526-531. PubMed ID: 29851531
[TBL] [Abstract][Full Text] [Related]
17. Next-Generation Sequencing of Retinoblastoma Identifies Pathogenic Alterations beyond RB1 Inactivation That Correlate with Aggressive Histopathologic Features.
Afshar AR; Pekmezci M; Bloomer MM; Cadenas NJ; Stevers M; Banerjee A; Roy R; Olshen AB; Van Ziffle J; Onodera C; Devine WP; Grenert JP; Bastian BC; Solomon DA; Damato BE
Ophthalmology; 2020 Jun; 127(6):804-813. PubMed ID: 32139107
[TBL] [Abstract][Full Text] [Related]
18. [Retinoblatoma: a review].
Doz F
Arch Pediatr; 2006 Oct; 13(10):1329-37. PubMed ID: 16930963
[TBL] [Abstract][Full Text] [Related]
19. [Retinoblastoma update].
Aerts I; Lumbroso-Le Rouic L; Gauthier-Villars M; Brisse H; Doz F
Arch Pediatr; 2016 Jan; 23(1):112-6. PubMed ID: 26679524
[TBL] [Abstract][Full Text] [Related]
20. Lack of correlation between age at diagnosis and RB1 mutations for unilateral retinoblastoma: the importance of genetic testing.
Berry JL; Lewis L; Zolfaghari E; Green S; Le BHA; Lee TC; Murphree AL; Kim JW; Jubran R
Ophthalmic Genet; 2018 Jun; 39(3):407-409. PubMed ID: 29286867
[No Abstract] [Full Text] [Related]
[Next] [New Search]
